Skip to Main Content

Author Details

Martijn J Schuemie
University of California los angeles
2001
182
44
PMIDPaper TitleJournal TitlePublished Year
38010062Bayesian safety surveillance with adaptive bias correction.Stat Med2024
38010062Bayesian safety surveillance with adaptive bias correction.Stat Med2024
36642826Adjusting for both sequential testing and systematic error in safety surveillance using observational data: Empirical calibration and MaxSPRT.Stat Med2023
37598737Padé approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes.J Biomed Inform2023
37829182Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.BMJ Med2023
37804398Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.Drug Saf2023
37952118European Health Data & Evidence Network-learnings from building out a standardized international health data network.J Am Med Inform Assoc2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
36642826Adjusting for both sequential testing and systematic error in safety surveillance using observational data: Empirical calibration and MaxSPRT.Stat Med2023
37328600Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.Drug Saf2023
37804398Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.Drug Saf2023
37952118European Health Data & Evidence Network-learnings from building out a standardized international health data network.J Am Med Inform Assoc2023
37829182Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.BMJ Med2023
37598737Padé approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes.J Biomed Inform2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
37328600Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.Drug Saf2023
34841975Combining cox regressions across a heterogeneous distributed research network facing small and zero counts.Stat Methods Med Res2022
36108816Adjusting for indirectly measured confounding using large-scale propensity score.J Biomed Inform2022
35392566Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.Front Pharmacol2022
35579348dPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profiling.J Am Med Inform Assoc2022
35811396Indirect covariate balance and residual confounding: An applied comparison of propensity score matching and cardinality matching.Pharmacoepidemiol Drug Saf2022
35810265Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.Drug Saf2022
35873596Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.Front Pharmacol2022
35680274Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.BMJ Open2022
35995107PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.J Biomed Inform2022
35614485Learning patient-level prediction models across multiple healthcare databases: evaluation of ensembles for increasing model transportability.BMC Med Inform Decis Mak2022
35482996Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study.JMIR Public Health Surveill2022
35354802DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.Nat Commun2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
36506524Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.Front Pharmacol2022
34841975Combining cox regressions across a heterogeneous distributed research network facing small and zero counts.Stat Methods Med Res2022
35680274Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.BMJ Open2022
35614485Learning patient-level prediction models across multiple healthcare databases: evaluation of ensembles for increasing model transportability.BMC Med Inform Decis Mak2022
35579348dPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profiling.J Am Med Inform Assoc2022
35392566Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.Front Pharmacol2022
35811396Indirect covariate balance and residual confounding: An applied comparison of propensity score matching and cardinality matching.Pharmacoepidemiol Drug Saf2022
35810265Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.Drug Saf2022
35482996Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study.JMIR Public Health Surveill2022
35354802DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.Nat Commun2022
36506524Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.Front Pharmacol2022
35873596Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.Front Pharmacol2022
36108816Adjusting for indirectly measured confounding using large-scale propensity score.J Biomed Inform2022
35995107PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.J Biomed Inform2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
33099616Erratum to: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study.J Am Med Inform Assoc2021
33791740Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.medRxiv2021
33454352Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer.Regul Toxicol Pharmacol2021
33882595Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI.Yearb Med Inform2021
33775125Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.Hypertension2021
34030640Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research.BMC Med Res Methodol2021
  • 1 - 50 of 364

Recommended Authors

Justin F Rousseau
University of Texas at Austin
Career Start Year 2018
Number of shared co-authors 0
Brett K Beaulieu-Jones
University of Chicago
Career Start Year 2016
Number of shared co-authors 9
James R Rogers
Columbia University
Career Start Year 2015
Number of shared co-authors 9
Jing Huang
Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 9
Vivek A Rudrapatna
University of California san francisco
Career Start Year 2012
Number of shared co-authors 5
Yue Yu
Health Sciences Mayo Clinic
Career Start Year 2012
Number of shared co-authors 1
Justin Bohn
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2012
Number of shared co-authors 1
Rishi J Desai
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 8
Orestis A Panagiotou
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 10
Chuan Hong
Harvard Medical School, USA Duke University
Career Start Year 2009
Number of shared co-authors 11
Alex Asiimwe
Bayer Pharma AG
Career Start Year 2009
Number of shared co-authors 6
Michael Fralick
University of Toronto
Career Start Year 2007
Number of shared co-authors 3
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 12
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 6
Chunhua Weng
Columbia University Irving Medical Center
Career Start Year 2002
Number of shared co-authors 35
Josh F Peterson
Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 9
Jiang Bian
College of Medicine, University of Florida
Career Start Year 2001
Number of shared co-authors 46
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 11
Pedro J Caraballo
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 5
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 3
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 3
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 15
Peggy L Peissig
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Career Start Year 1996
Number of shared co-authors 8
Antoine Neuraz
INSERM UMR 3, Universite Paris Cite, Imagine Institute
Career Start Year 1994
Number of shared co-authors 8
John P A Ioannidis
Stanford University
Career Start Year 1994
Number of shared co-authors 4
William R Hogan
College of Medicine, University of Florida
Career Start Year 1990
Number of shared co-authors 8
Til St??rmer
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 12
Mark G Weiner
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 8
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 9

Collaborators

Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers 87
Marc A Suchard
University of California los angeles
Co-authored papers 48
George Hripcsak
Columbia University
Co-authored papers 43
Miriam C J M Sturkenboom
University Medical Center Utrecht
Co-authored papers 42
David Madigan
Columbia University.
Co-authored papers 35
Johan van der Lei
Erasmus Medical Center
Co-authored papers 25
Gianluca Trifirò
Co-authored papers 23
Jan A Kors
Erasmus MC - University Medical Center Rotterdam
Co-authored papers 21
Peter R Rijnbeek
Erasmus University Medical Center
Co-authored papers 20
Nicole L Pratt
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Co-authored papers 19
Christian Reich
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 18
Rae Woong Park
Ajou University Graduate School of Medicine
Co-authored papers 18
Seng Chan You
Yonsei University College of Medicine
Co-authored papers 16
Talita Duarte-Salles
Erasmus University Medical Center
Co-authored papers 13
Jesse A Berlin
Rutgers University School of Public Health
Co-authored papers 13
Daniel Prieto-Alhambra
University of Oxford
Co-authored papers 12
Harlan M Krumholz
Yale School of Medicine
Co-authored papers 12
Jon Duke
Georgia Tech Research Institute, Georgia Tech College of Computing
Co-authored papers 10
Thamir M Alshammari
Riyadh Elm University
Co-authored papers 10
Barend Mons
Leiden University Medical Center
Co-authored papers 9
Erik M van Mulligen
Erasmus University Medical Center
Co-authored papers 9
James Weaver
Janssen Pharmaceutical Research & Development
Co-authored papers 9
Fred Nyberg
University of Gothenburg
Co-authored papers 9
Frank DeFalco
Janssen Pharmaceutical Research & Development
Co-authored papers 9
Nigam H Shah
Stanford University
Co-authored papers 9
Michael Matheny
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 8
Ruijun Chen
USA Tempus Labs Inc.
Co-authored papers 8
Jenna M Reps
Erasmus University Medical Center
Co-authored papers 8
Paul Avillach
Harvard Medical School
Co-authored papers 7
Scott L DuVall
University of Utah
Co-authored papers 7
Release 1.2